Covering the operations of the oil and gas industry
General Interest
Refining & Processing
Drilling & Production
Exploration & Development
Pipelines & Transportation
Sections
General Interest
Refining & Processing
Drilling & Production
Exploration & Development
Pipelines & Transportation
LNG
Energy Transition
Industry Statistics
Members Only
Special
Webcasts
White Papers
Podcast
Magazine
Surveys
Research
Events
Submit an Article
Contact
About Us
Subscribe
Newsletters
Advertise
Contact Us
Privacy Policy
Terms & Conditions
Affiliated Brands
OFFSHORE
ENERGYTECH
MICROGRID KNOWLEDGE
OGJ RESEARCH
Follow us on
http://www.facebook.com/ogjonline
https://www.linkedin.com/company/oil-&-gas-journal
http://twitter.com/ogjonline
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
PennEnergy Stock Watch
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
NuCana plc - American Depositary Shares
(NQ:
NCNA
)
4.210
+0.040 (+0.96%)
Streaming Delayed Price
Updated: 9:49 AM EST, Dec 8, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about NuCana plc - American Depositary Shares
< Previous
1
2
Next >
NuCana Reports Third Quarter 2025 Financial Results and Provides Business Update
November 13, 2025
From
NuCana plc
Via
GlobeNewswire
NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in China
November 05, 2025
From
NuCana plc
Via
GlobeNewswire
NuCana Presents Encouraging Data on NUC-7738 in Combination with PD-1 Inhibitors using Primary Patient-Derived Organoids and Autologous Tumor-Infiltrating Lymphocytes at the ESMO Congress 2025
October 18, 2025
From
NuCana plc
Via
GlobeNewswire
NuCana Announces Encouraging Data for NUC-3373 in Combination with Anti-PD-1 Therapy
October 14, 2025
From
NuCana plc
Via
GlobeNewswire
NuCana Compliant with All Nasdaq Continued Listing Criteria
September 05, 2025
Anticipated Cash Runway into 2029
From
NuCana plc
Via
GlobeNewswire
NuCana to Present Data on NUC-7738’s Synergy with PD-1 Inhibitors at the ESMO Congress 2025
September 03, 2025
From
NuCana plc
Via
GlobeNewswire
NuCana Reports Second Quarter 2025 Financial Results and Provides Business Update
August 20, 2025
From
NuCana plc
Via
GlobeNewswire
NuCana Announces ADS Ratio Change
August 01, 2025
From
NuCana plc
Via
GlobeNewswire
Element79 Gold Corp Shifts Focus to US Projects and Appoints New VP of Corporate Development – More Stocks Inside
July 22, 2025
Via
AB Newswire
NuCana Cancels All Outstanding Series A Warrants Following Strategic ATM Execution
July 21, 2025
From
NuCana plc
Via
GlobeNewswire
Micro-Cap Surge: NCNA, HCTI, SPZI, PNPN.V in MedTech, AI, Healthcare, Energy, Metals, Minerals, Etc. – More Stocks Inside
July 16, 2025
Via
AB Newswire
Topics
Artificial Intelligence
NuCana Announces Plan to Implement ADS Ratio Change
July 11, 2025
From
NuCana plc
Via
GlobeNewswire
Clifton Mining (OTC: CFTN) Ramps Up Mining Operations – More Stocks Inside
July 02, 2025
Via
AB Newswire
NuCana Reports First Quarter 2025 Financial Results and Provides Business Update
June 02, 2025
From
NuCana plc
Via
GlobeNewswire
Pennies on the Rise: HCTI, SWISF, ADHC, NCNA Gain Traction Amid LargeCap Uncertainty – More Stocks Inside
May 19, 2025
Via
AB Newswire
NuCana Prices $7 Million Registered Direct Offering
May 06, 2025
From
NuCana plc
Via
GlobeNewswire
Stocks Under $1 To Watch: $NITO, $SPRC, $PNPNF, $NCNA, $PRSO – Multi-Sectors Momentum Building more inside…
May 05, 2025
Via
AB Newswire
Topics
Intellectual Property
NuCana Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Update
March 20, 2025
From
NuCana plc
Via
GlobeNewswire
NuCana Reports Third Quarter 2024 Financial Results and Provides Business Update
November 25, 2024
From
NuCana plc
Via
GlobeNewswire
NuCana Announces Encouraging Initial Data from Phase 1b/2 Modular Study of NUC-3373 in Combination with Pembrolizumab or Docetaxel
November 11, 2024
From
NuCana plc
Via
GlobeNewswire
NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in the United States
September 25, 2024
From
NuCana plc
Via
GlobeNewswire
NuCana Presents Encouraging Data on NUC-7738 in Combination with Pembrolizumab in PD-1 Inhibitor Refractory and Resistant Melanoma Patients at the ESMO Congress 2024
September 14, 2024
Combination of NUC-7738 plus Pembrolizumab Resulted in Prolonged Progression Free Survival, a Compelling Disease Control Rate including Partial Responses, and a Favorable Safety Profile
From
NuCana plc
Via
GlobeNewswire
NuCana Announces Update for Phase 2 Randomized Colorectal Cancer Study
August 29, 2024
From
NuCana plc
Via
GlobeNewswire
NuCana Reports Second Quarter 2024 Financial Results and Provides Business Update
August 15, 2024
From
NuCana plc
Via
GlobeNewswire
NuCana to Present at the Jefferies Global Healthcare Conference
May 30, 2024
From
NuCana plc
Via
GlobeNewswire
NuCana to Present at TD Cowen’s 5th Annual Oncology Innovation Summit
May 21, 2024
From
NuCana plc
Via
GlobeNewswire
NuCana Reports First Quarter 2024 Financial Results and Provides Business Update
May 16, 2024
From
NuCana plc
Via
GlobeNewswire
NuCana Regains Compliance with Nasdaq Minimum Bid Price Requirement
May 01, 2024
From
NuCana plc
Via
GlobeNewswire
NuCana Announces Completion of ADS Ratio Change
April 16, 2024
From
NuCana plc
Via
GlobeNewswire
NuCana Presents Data at the AACR 2024 Annual Meeting Highlighting the Ability of NUC-7738 to Profoundly Alter Tumor Biology in a Paired Biopsy Clinical Study
April 09, 2024
From
NuCana plc
Via
GlobeNewswire
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
